Similarly, the NND group’s NUPR1 promoter methylation level showed a substantially higher median [IQR] (98.00 [95.00, 100.00]) than the GBM group’s (65.00 [23.00, 87.00]) (p < 0.001, Mann–Whitney U test). This evidence concerns the gene NUPR1 and glioblastoma.